NACT upregulated STING, PD-L1 and IFN-β protein expression in cGAS-STING pathway in NSCLC and increased CD3+ lymphocyte and CD8+ lymphocyte infiltration, suggesting the potential of NACT for sensitizing immunotherapy. This evidence concerns the gene STING1 and non-small cell lung carcinoma.